Arbutus Biopharma Corporation (ABUS)

Arbutus Biopharma Revenue

Arbutus Biopharma had revenue of $179.13M in the quarter ending March 31, 2026, with 10,054.54% growth. This brings the company's revenue in the last twelve months to $191.45M, up 2,889.93% year-over-year. In the year 2025, Arbutus Biopharma had annual revenue of $14.08M with 128.21% growth.

• Revenue (ttm): $191.45M
• Revenue Growth: +2,889.93%
• P/S Ratio: 4.49
• Revenue / Employee: $10,076,053
• Employees: 19
• Market Cap: 837.56M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	14.08M	7.91M	128.21%
Dec 31, 2024	6.17M	-11.97M	-65.98%
Dec 31, 2023	18.14M	-20.88M	-53.51%
Dec 31, 2022	39.02M	28.03M	255.11%
Dec 31, 2021	10.99M	4.07M	58.92%
Dec 31, 2020	6.91M	903.00K	15.02%
Dec 31, 2019	6.01M	66.00K	1.11%
Dec 31, 2018	5.95M	-4.76M	-44.44%
Dec 31, 2017	10.70M	9.21M	617.64%
Dec 31, 2016	1.49M	-21.79M	-93.59%
Dec 31, 2015	23.28M	8.32M	55.66%
Dec 31, 2014	14.95M	-512.00K	-3.31%
Dec 31, 2013	15.47M	1.36M	9.64%
Dec 31, 2012	14.11M	-2.19M	-13.44%
Dec 31, 2011	16.30M	-5.13M	-23.95%
Dec 31, 2010	21.43M	7.66M	55.67%
Dec 31, 2009	13.76M	-	-

Data Source: Fiscal.ai Last updated: May 13, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 16, 2026

Data Sources Report a data error